Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent abuse of prescription opioids.
Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.
Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.
Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.
Permits prescription labels for medication abortion prescription drugs to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Relates to the labeling of food products containing sesame.
Enacts the "foreign drug transparency act"; requires the disclosure to a health plan, pharmacy and patient whether a prescription drug was manufactured or compounded in a foreign country; whether the prescription was approved by the federal food and drug administration foreign drug inspection program; requires the date of the last inspection of such prescription drug by the federal food and drug administration foreign drug inspection program; requires certain labelling on such drugs.